The prescription of oral anticancer drugs: Another perspective

Reports of Practical Oncology and Radiotherapy

Volumn 17, Issue 6, 2012, Pages 295-297

  Linares, Luis ^a   Poitevin, Adela ^b   De la Pena, Cuauhtemoc ^c   Britton, Keith R ^d   Ospino, Rosalba ^e   Lara, Raul ^f   Sarria, Gustavo ^g   Motta, Neiro ^h   Rene, Nicholas ⁱ   Pinillos, Luis ^j   Novaes, Paulo ^k  

^a HOPE International Radiation Center   (Guatemala)

^b Médica Sur ^*  (Mexico)

^c Christus Hospital   (Mexico)

^d Centro Internacional de Radiocirugía y Radioterapia Oncológica CIRRO   (Panama)

^e Instituto Nacional de Cancerología   (Colombia)

^f Centro Salvadoreño de Radioterapia   (El Salvador)

^g INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^h UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

ⁱ Centro de Radioterapia   (Argentina)

^j AUNA Delgado Private Hospital   (Peru)

^k Radioterapia ISO Hospital Dia Santos   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; EDITORIAL; HUMAN; MEDICAL CARE; PRESCRIPTION;

EID: 84870743360     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.10.005     Document Type: Editorial

References (15)

1. Ramos A., Torrecilla J.L., Lara P., et al. Should the prescription of oral anticancer drugs be restricted?. Rep Pract Oncol Radiother 2012, 17(July (4)):187-189.
2. Colomer R., Alba E., González-Martin A., et al. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol 2010, 21(February (2)):195-198.
3. Guedea F., Macià M., Sanchez Calzado J.A., et al. Treatment of cancer with drugs: a controversy. Ann Oncol 2011, 22(March (3)):747-748.
4. Guedea F. The role of the radiation oncologist in oncology today. Clin Transl Oncol 2010, 12(December (12)):779-780.
5. Galofré J.C., Gómez-Sáez J.M., Escola C.A., et al. Treatment of thyroid cancer with the new oral agents. Ann Oncol 2011, 22(October (10)):2343.
6. Velenik V., Ocvirk J., Oblak I., Anderluh F. Cetuximab in preoperative treatment of rectal cancer-term outcome of the XERT trial. Radiol Oncol 2012, 46(September (3)):252-257.
7. Oblak I., Petric P., Anderluh F., Velenik V., Fras P. Long term outcome after combined modality treatment for anal cancer. Radiol Oncol 2012, 46(June (2)):145-152.
8. Tezcan Y., Koc M. 3-D conformal radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma multiforme and evaluation of prognostic factors. Radiol Oncol 2011, 45(September (3)):213-219.
9. Bernad D., Zysnarska M., Adamek R. Social support for cancer-selected problems. Rep Pract Oncol Radiother 2010, 15(March (2)):47-50.
10. Boyle F.M., Robinson E., Dunn S.M., Heinrich P.C. Multidisciplinary care in cancer: the fellowship of the ring. JCO 2005, 23(February (4)):916-920.
11. Herruzo I., Romero J., Palacios A. The white book of radiation oncology in Spain. Clin Transl Oncol 2011, 13(June (6)):385-395.
12. Guedea F., Ramos A. The importance of the White Book of Radiation Oncology. Clin Trans Oncol 2011, 13(6):355-356.
13. Zietman A. The future of radiation oncology: the evolution, diversification, and survival of the specialty. Semin Radiat Oncol 2008, 18(July (3)):207-213.
14. Connell P.P., Hellman S. Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res 2009, 69(January (2)):383-392.
15. Sánchez-Santos M.E. Therapeutic applications of ionizing radiations. Radiation damage in biomolecular systems 2012, 397-409. Springer, Netherlands, Available from: http://www.springerlink.com/content/l6g800811346v353/abstract/ [cited 16.10.12; Internet]. G. García Gómez-Tejedor, M.C. Fuss (Eds.).